These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 38333977)

  • 1. The Diagnostic Value of Ultrasound-guided Attenuation Parameter (UGAP) in metabolic fatty liver disease.
    Wu H; Zeng Y; Chen F; Peng J; Chen L
    Curr Med Imaging; 2024 Feb; ():. PubMed ID: 38333977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
    Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
    J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered probe pressure and body position increase diagnostic accuracy for men and women in detecting hepatic steatosis using quantitative ultrasound.
    Byenfeldt M; Kihlberg J; Nasr P; Grönlund C; Lindam A; Bartholomä WC; Lundberg P; Ekstedt M
    Eur Radiol; 2024 Sep; 34(9):5989-5999. PubMed ID: 38459346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Igarashi Y
    JGH Open; 2021 Aug; 5(8):947-952. PubMed ID: 34386604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.
    Cannella R; Agnello F; Porrello G; Spinello AU; Infantino G; Pennisi G; Cabibi D; Petta S; Bartolotta TV
    Eur Radiol; 2024 Oct; ():. PubMed ID: 39373742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?
    Seo DM; Lee SM; Park JW; Kim MJ; Ha HI; Park SY; Lee K
    Ultrasonography; 2023 Apr; 42(2):227-237. PubMed ID: 36935602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method.
    Bende F; Sporea I; Șirli R; Bâldea V; Lazăr A; Lupușoru R; Fofiu R; Popescu A
    Med Ultrason; 2021 Feb; 23(1):7-14. PubMed ID: 33220028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Shen Q; Hao Y; Chen J; Liu Q; Jia H; Liu L
    Curr Med Imaging; 2024; 20():1-12. PubMed ID: 38389362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Utility of Ultrasound-Guided Attenuation Parameter for the Detection and Quantification of Hepatic Steatosis in Patients with Fatty Liver Diagnosed by Computed Tomography.
    Iwashita H; Shakado S; Yoshimaru N; Tanaka H; Koto F; Tanaka T; Takata K; Yokoyama K; Yamaguchi M; Irie M; Hirai F
    Ultrasound Med Biol; 2022 Jul; 48(7):1282-1289. PubMed ID: 35397929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Ultrasound-Guided Attenuation Parameter for Grading Steatosis With Reference to MRI-PDFF in a Large Cohort.
    Imajo K; Toyoda H; Yasuda S; Suzuki Y; Sugimoto K; Kuroda H; Akita T; Tanaka J; Yasui Y; Tamaki N; Kurosaki M; Izumi N; Nakajima A; Kumada T
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2533-2541.e7. PubMed ID: 34768008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease.
    Jeon SK; Lee JM; Joo I; Yoon JH
    Ultrasonography; 2022 Apr; 41(2):355-364. PubMed ID: 34933319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility of ultrasound-guided attenuation parameter (UGAP) to the noninvasive evaluation of hepatic steatosis.
    Zhao Y; Jia M; Zhang C; Feng X; Chen J; Li Q; Zhang Y; Xu W; Dong Y; Jiang Y; Liu Y; Huang P
    Sci Rep; 2022 Feb; 12(1):2876. PubMed ID: 35190618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
    Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
    Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of a novel ultrasound-based quantitative method to assess liver steatosis in histologically identified nonalcoholic fatty liver disease.
    Kang KA; Lee SR; Jun DW; Do IG; Kim MS
    Med Ultrason; 2023 Mar; 25(1):7-13. PubMed ID: 36780603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation Coefficient Measurement Using a High-Frequency (2-9 MHz) Convex Transducer for Children Including Fatty Liver.
    Yoon H; Kim J; Lim HJ; Kamiyama N; Oguri T; Koh H; Lee MJ
    Ultrasound Med Biol; 2022 Jun; 48(6):1070-1077. PubMed ID: 35296397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Ultrasound-Guided Attenuation Parameter (UGAP) in Renal Angiomyolipoma (AML): First Results.
    Kranert PC; Kranert P; Banas MC; Jung EM; Banas B; Putz FJ
    Diagnostics (Basel); 2024 Sep; 14(18):. PubMed ID: 39335680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.
    Tada T; Kumada T; Toyoda H; Kobayashi N; Sone Y; Oguri T; Kamiyama N
    AJR Am J Roentgenol; 2019 Feb; 212(2):332-341. PubMed ID: 30476453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and stability of ultrasound-guided attenuation parameter in evaluating hepatic steatosis.
    Zhang X; Luo L; Liu H; Liang S; Xu E
    J Ultrasound; 2024 Mar; 27(1):145-152. PubMed ID: 38281291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis.
    Tada T; Kumada T; Toyoda H; Yasuda S; Sone Y; Hashinokuchi S; Ogawa S; Oguri T; Kamiyama N; Chuma M; Akita T; Tanaka J
    Hepatol Res; 2020 Feb; 50(2):190-198. PubMed ID: 31661724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.